2 days Ago hapabapa Leerink has upgraded AbbVie ( NYSE: ABBV ) to outperform from market perform, commenting that the recent sell-off in the shares has created a buying opportunity. “We believe investors can take advantage of the emraclidine setback and election-related downdraft to purchase shares in.
